Patent details

EP1696960 Title: INTRANASAL ADMINISTRATION OF GLUCOSE-REGULATING PEPTIDES

Basic Information

Publication number:
EP1696960
PCT Application Number:
PCT/US/2004/043312
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP048153936
PCT Publication Number:
WO/2005/065714
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INTRANASAL ADMINISTRATION OF GLUCOSE-REGULATING PEPTIDES
French Title of Invention:
ADMINISTRATION INTRANASALE DE PEPTIDES REGULANT LE GLUCOSE
German Title of Invention:
INTRANASALE VERABREICHUNG VON GLUCOSE-REGULIERENDEN PEPTIDEN
SPC Number:

Dates

Filing date:
17/12/2004
Grant date:
08/09/2010
EP Publication Date:
08/09/2010
PCT Publication Date:
21/07/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/09/2006
EP B1 Publication Date:
08/09/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
17/12/2010
Expiration date:
17/12/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/12/2004
 
 

Name:
Amylin Pharmaceuticals Inc.
Address:
9360 Towne Centre Drive, San Diego, CA 92121, United States (US)

Inventor

1

Name:
COSTANTINO Henry, R.
Address:
United States (US)

2

Name:
QUAY Steven, C.
Address:
United States (US)

Priority

Priority Number:
532337 P
Priority Date:
26/12/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 47/00;
Filing date Document type Number of pages